Electroencephelographs (EEG) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

EEG Pipeline Market Report Overview

Electroencephalograms are used to diagnose issues related to the electrical activity of the brain. The EEG consists of electrodes placed on the scalp that records brain wave patterns. EEGs are used to detect various brain-related conditions, including seizures, head injuries, brain tumors, sleep disorders, stroke, and dementia. One unit refers to one EEG machine.

The EEG pipeline market research report provides comprehensive information about the EEG pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories The US, Europe, China, Japan, and South Korea
Key Regulatory Paths 510(k), PMA, CE, NMPA, TGA, Ninsho, and De Novo
Leading Companies AAT Medical Ltd, Advanced Medical Electronics Corp, Advanced Neurometrics Inc (Inactive), Avertus Inc, BioSignal Analytics Inc, and Bio-Signal Group Corp

EEG Pipeline Market Segmentation by Territories

Some of the key territories in the EEG market are the US, Europe, China, Japan, and South Korea among others. As of May 2023, the US has the highest number of pipeline products.

EEG Pipeline Market Analysis, by Territories, 2023 (%)

EEG Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the EEG pipeline market, download a free report sample

EEG Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the EEG pipeline market are 510(k), PMA, CE, NMPA, TGA, Ninsho, and De Novo among others. As of May 2023, 510(k) is the most followed pathway for pipeline products.

EEG Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

EEG Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the EEG pipeline market, download a free report sample

EEG Pipeline Market – Competitive Landscape

Some of the key companies in the EEG pipeline market are AAT Medical Ltd, Advanced Medical Electronics Corp, Advanced Neurometrics Inc (Inactive), Avertus Inc, BioSignal Analytics Inc, and Bio-Signal Group Corp among others.

Advanced Medical Electronics Corp Company Overview: Advanced Medical Electronics Corp (AME) is a medical device company that provides research and development services. The company‘s products include electrocardiograph and spirometer equipment. It also provides a battery-powered surgical headlamp, wrist-worn pulse oximeter, electroencephalograph, partial polysomnography, diagnostic spirometer, and computerized visual acuity testing. AME offers services such as systems design, embedded design, electronics and instrumentation design, wireless design, software development, prototype build, and system testing. The company has partnerships with universities, healthcare agencies, and cancer institutes, among others. AME is headquartered in Maple Grove, Minnesota, the US.

Segments Covered in the Report

EEG Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Japan
  • Australia
  • South Korea

EEG Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • PMA
  • CE
  • NMPA
  • TGA
  • Ninsho
  • De Novo

Scope

  • Extensive coverage of the EEG under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of EEG and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of EEG under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

AAT Medical Ltd
Advanced Medical Electronics Corp
Advanced Neurometrics Inc (Inactive)
Avertus Inc
BioSignal Analytics Inc
Bio-Signal Group Corp.
BrainCare OY
BrainScope Company Inc
Byteflies
Ceribell Inc
Cerora Inc
Circadian Therapeutics
Cleveland Medical Devices Inc
Cognionics, Inc.
Cogwear LLC
Compumedics Ltd
Electrical Geodesics Inc
Emosis Pte Ltd
Epi-Minder Pty Ltd
Ewear Technologies LLC
g.tec medical engineering GmbH
HEARD Medical
IMEC
iMediSync Inc
Infinite Biomedical Technologies LLC
Innovative Biomedical Instruments and Systems
Korwave
Memory MD Inc
Mindful Scientific Inc.
Neba Health, LLC
Neuro Assessment Systems
Neurolutions, Inc.
NeuroOne Medical Technologies Corp
NeuroServo Inc
Neuroverse Inc
NeuroVigil Inc
NeuroWave Systems Inc
Optima Neuroscience Inc
QUASAR, Inc.
Rice University
Shenzhen Med-link Electronics Tech Co., Ltd
Skolkovo Institute of Science and Technology
Sumitomo Pharma Co Ltd
UNEEG Medical A/S
University College Cork
University of California Los Angeles
University of Colorado
University of Florida
University of Helsinki
University of Hertfordshire
University of Michigan
University of Tsukuba
University Rovira i Virgili
Wyss Center for Bio and Neuro Engineering

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Electroencephelographs (EEG) Overview

  • 3 Products under Development

    • 3.1 Electroencephelographs (EEG) – Pipeline Products by Stage of Development
    • 3.2 Electroencephelographs (EEG) – Pipeline Products by Territory
    • 3.3 Electroencephelographs (EEG) – Pipeline Products by Regulatory Path
    • 3.4 Electroencephelographs (EEG) – Pipeline Products by Estimated Approval Date
    • 3.5 Electroencephelographs (EEG) – Ongoing Clinical Trials

  • 4 Electroencephelographs (EEG) – Pipeline Products under Development by Companies

    • 4.1 Electroencephelographs (EEG) Companies – Pipeline Products by Stage of Development
    • 4.2 Electroencephelographs (EEG) – Pipeline Products by Stage of Development

  • 5 Electroencephelographs (EEG) Companies and Product Overview

    • 5.1 AAT Medical Ltd Company Overview

      • 5.1.1 AAT Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Advanced Medical Electronics Corp Company Overview

      • 5.2.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Advanced Neurometrics Inc (Inactive) Company Overview

      • 5.3.1 Advanced Neurometrics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Avertus Inc Company Overview

      • 5.4.1 Avertus Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 BioSignal Analytics Inc Company Overview

      • 5.5.1 BioSignal Analytics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Bio-Signal Group Corp. Company Overview

      • 5.6.1 Bio-Signal Group Corp. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 BrainCare OY Company Overview

      • 5.7.1 BrainCare OY Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 BrainScope Company Inc Company Overview

      • 5.8.1 BrainScope Company Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Byteflies Company Overview

      • 5.9.1 Byteflies Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Ceribell Inc Company Overview

      • 5.10.1 Ceribell Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Cerora Inc Company Overview

      • 5.11.1 Cerora Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Circadian Therapeutics Company Overview

      • 5.12.1 Circadian Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Cleveland Medical Devices Inc Company Overview

      • 5.13.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Cognionics, Inc. Company Overview

      • 5.14.1 Cognionics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Cogwear LLC Company Overview

      • 5.15.1 Cogwear LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Compumedics Ltd Company Overview

      • 5.16.1 Compumedics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Electrical Geodesics Inc Company Overview

      • 5.17.1 Electrical Geodesics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Emosis Pte Ltd Company Overview

      • 5.18.1 Emosis Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Epi-Minder Pty Ltd Company Overview

      • 5.19.1 Epi-Minder Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Ewear Technologies LLC Company Overview

      • 5.20.1 Ewear Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 g.tec medical engineering GmbH Company Overview

      • 5.21.1 g.tec medical engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 HEARD Medical Company Overview

      • 5.22.1 HEARD Medical Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 IMEC Company Overview

      • 5.23.1 IMEC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 iMediSync Inc Company Overview

      • 5.24.1 iMediSync Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 Infinite Biomedical Technologies LLC Company Overview

      • 5.25.1 Infinite Biomedical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Innovative Biomedical Instruments and Systems Company Overview

      • 5.26.1 Innovative Biomedical Instruments and Systems Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 Korwave Company Overview

      • 5.27.1 Korwave Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 Memory MD Inc Company Overview

      • 5.28.1 Memory MD Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.29 Mindful Scientific Inc. Company Overview

      • 5.29.1 Mindful Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.30 Neba Health, LLC Company Overview

      • 5.30.1 Neba Health, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.31 Neuro Assessment Systems Company Overview

      • 5.31.1 Neuro Assessment Systems Pipeline Products & Ongoing Clinical Trials Overview

    • 5.32 Neurolutions, Inc. Company Overview

      • 5.32.1 Neurolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.33 NeuroOne Medical Technologies Corp Company Overview

      • 5.33.1 NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.34 NeuroServo Inc Company Overview

      • 5.34.1 NeuroServo Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.35 Neuroverse Inc Company Overview

      • 5.35.1 Neuroverse Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.36 NeuroVigil Inc Company Overview

      • 5.36.1 NeuroVigil Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.37 NeuroWave Systems Inc Company Overview

      • 5.37.1 NeuroWave Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.38 Optima Neuroscience Inc Company Overview

      • 5.38.1 Optima Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.39 QUASAR, Inc. Company Overview

      • 5.39.1 QUASAR, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.40 Rice University Company Overview

      • 5.40.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.41 Shenzhen Med-link Electronics Tech Co., Ltd Company Overview

      • 5.41.1 Shenzhen Med-link Electronics Tech Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.42 Skolkovo Institute of Science and Technology Company Overview

      • 5.42.1 Skolkovo Institute of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.43 Sumitomo Pharma Co Ltd Company Overview

      • 5.43.1 Sumitomo Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.44 UNEEG Medical A/S Company Overview

      • 5.44.1 UNEEG Medical A/S Pipeline Products & Ongoing Clinical Trials Overview

    • 5.45 University College Cork Company Overview

      • 5.45.1 University College Cork Pipeline Products & Ongoing Clinical Trials Overview

    • 5.46 University of California Los Angeles Company Overview

      • 5.46.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

    • 5.47 University of Colorado Company Overview

      • 5.47.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

    • 5.48 University of Florida Company Overview

      • 5.48.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview

    • 5.49 University of Helsinki Company Overview

      • 5.49.1 University of Helsinki Pipeline Products & Ongoing Clinical Trials Overview

    • 5.50 University of Hertfordshire Company Overview

      • 5.50.1 University of Hertfordshire Pipeline Products & Ongoing Clinical Trials Overview

    • 5.51 University of Michigan Company Overview

      • 5.51.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

    • 5.52 University of Tsukuba Company Overview

      • 5.52.1 University of Tsukuba Pipeline Products & Ongoing Clinical Trials Overview

    • 5.53 University Rovira i Virgili Company Overview

      • 5.53.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview

    • 5.54 Wyss Center for Bio and Neuro Engineering Company Overview

      • 5.54.1 Wyss Center for Bio and Neuro Engineering Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Electroencephelographs (EEG)- Recent Developments

    • 6.1 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • 6.2 Apr 12, 2023: Medtronic has a layoff in California
    • 6.3 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • 6.4 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023
    • 6.5 Feb 01, 2023: New EEG procedure accurately measures distress caused by tinnitus
    • 6.6 Nov 25, 2022: Beyond the Smartwatch: Three Wearable Technology Trends to Watch
    • 6.7 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.8 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • 6.9 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.10 Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023
    • 6.11 Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results
    • 6.12 Sep 19, 2022: Masimo names Blair Tripodi as COO for consumer division
    • 6.13 Sep 07, 2022: Medtronic to appear at September investor conferences
    • 6.14 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • 6.15 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • 6.16 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • 6.17 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • 6.18 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Electroencephelographs (EEG) – Pipeline Products by Stage of Development 13

Electroencephelographs (EEG) – Pipeline Products by Territory 14

Electroencephelographs (EEG) – Pipeline Products by Regulatory Path 15

Electroencephelographs (EEG) – Pipeline Products by Estimated Approval Date 16

Electroencephelographs (EEG) – Ongoing Clinical Trials 17

Electroencephelographs (EEG) Companies – Pipeline Products by Stage of Development 18

Electroencephelographs (EEG) – Pipeline Products by Stage of Development 21

AAT Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Mente Autism – Product Status 23

Mente Autism – Product Description 24

AAT Medical Ltd – Ongoing Clinical Trials Overview 25

Mente Autism – Phase I/II Study to Assess the Safety and the Efficacy of the Novel NTI/Dolce Strains in a Paediatric Population, along with the Efficacy of the Mente Device When Used in Combination with the Novel NTI/Dolce Medicinal Cannabis Strains 26

Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 27

POC aEEG Monitor – Product Status 27

POC aEEG Monitor – Product Description 27

Advanced Neurometrics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

ANI-SI EEG System – Product Status 28

ANI-SI EEG System – Product Description 28

Avertus Inc Pipeline Products & Ongoing Clinical Trials Overview 29

10 Channel HALO Configuration Dry Wireless Ambulatory Device – Product Status 29

10 Channel HALO Configuration Dry Wireless Ambulatory Device – Product Description 29

BioSignal Analytics Inc Pipeline Products & Ongoing Clinical Trials Overview 30

AutoEEG – Product Status 30

AutoEEG – Product Description 30

Bio-Signal Group Corp. Pipeline Products & Ongoing Clinical Trials Overview 31

Wireless MicroEEG – Neonatal Apnea – Product Status 31

Wireless MicroEEG – Neonatal Apnea – Product Description 31

BrainCare OY Pipeline Products & Ongoing Clinical Trials Overview 32

UltimateEEG – Product Status 32

UltimateEEG – Product Description 32

BrainScope Company Inc Pipeline Products & Ongoing Clinical Trials Overview 33

BrainScope Device – Alzheimer’s Disease – Product Status 33

BrainScope Device – Alzheimer’s Disease – Product Description 33

BrainScope Device – Depression – Product Status 34

BrainScope Device – Depression – Product Description 34

BrainScope Device – Seizure – Product Status 34

BrainScope Device – Seizure – Product Description 35

BrainScope Device – Stroke – Product Status 35

BrainScope Device – Stroke – Product Description 35

Byteflies Pipeline Products & Ongoing Clinical Trials Overview 36

Byteflies Kit – Neurodegenerative Disease – Product Status 36

Byteflies Kit – Neurodegenerative Disease – Product Description 36

EpiCare@Home – Product Status 37

EpiCare@Home – Product Description 37

Byteflies – Ongoing Clinical Trials Overview 38

EpiCare@Home – Validation Study for Monitoring of Focal Onset Epileptic Seizures With a Wearable Seizure Monitoring Device, EpiCare@Home 39

Ceribell Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Ceribell Pocket EEG Device – Delirium – Product Status 40

Ceribell Pocket EEG Device – Delirium – Product Description 40

Cerora Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Cerora Borealis – Product Status 41

Cerora Borealis – Product Description 41

MindReader – Product Status 42

MindReader – Product Description 42

MindReader – Autism – Product Status 42

MindReader – Autism – Product Description 43

MindReader – Neurodegenerative Conditions – Product Status 43

MindReader – Neurodegenerative Conditions – Product Description 43

Circadian Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 44

Circaid EEG – Product Status 44

Circaid EEG – Product Description 44

Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Electroencephalogram Electrode – Product Status 45

Electroencephalogram Electrode – Product Description 45

Cognionics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46

EEG Headset System – Product Status 46

EEG Headset System – Product Description 46

Stress/Strain Monitoring Device – Product Status 47

Stress/Strain Monitoring Device – Product Description 47

Cogwear LLC Pipeline Products & Ongoing Clinical Trials Overview 48

EEG Device – Product Status 48

EEG Device – Product Description 48

Compumedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Long Term Epilepsy Monitoring Device – Product Status 49

Long Term Epilepsy Monitoring Device – Product Description 49

Electrical Geodesics Inc Pipeline Products & Ongoing Clinical Trials Overview 50

dEEG/NIRS System – Infants – Product Status 50

dEEG/NIRS System – Infants – Product Description 50

EEG Ink Net – Product Status 51

EEG Ink Net – Product Description 51

Emosis Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Emosis Headband – Product Status 52

Emosis Headband – Product Description 52

Epi-Minder Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

Minder – Product Status 53

Minder – Product Description 53

Epi-Minder Pty Ltd – Ongoing Clinical Trials Overview 54

Minder – A Prospective Study to Assess the Safety of a Sub-scalp Monitoring Device for the Recording of Brain Electrical Activity Associated with the Occurrence of Epileptic Seizures 55

Ewear Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 56

EEG Sensor – Product Status 56

EEG Sensor – Product Description 56

g.tec medical engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 57

mindBEAGLE – Product Status 57

mindBEAGLE – Product Description 57

HEARD Medical Pipeline Products & Ongoing Clinical Trials Overview 58

Dry EEG Sensor – Bioamplifer System – Product Status 58

Dry EEG Sensor – Bioamplifer System – Product Description 58

IMEC Pipeline Products & Ongoing Clinical Trials Overview 59

Eight Channel Wireless EEG Headset – Product Status 59

Eight Channel Wireless EEG Headset – Product Description 59

iMediSync Inc Pipeline Products & Ongoing Clinical Trials Overview 60

iSyncWave – Product Status 60

iSyncWave – Product Description 60

Infinite Biomedical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 61

Neonatal Neurological Monitor (N2M) – Product Status 61

Neonatal Neurological Monitor (N2M) – Product Description 61

Innovative Biomedical Instruments and Systems Pipeline Products & Ongoing Clinical Trials Overview 62

Electroencephelograph System – Product Status 62

Electroencephelograph System – Product Description 62

Korwave Pipeline Products & Ongoing Clinical Trials Overview 63

Korwave – Product Status 63

Korwave – Product Description 63

Memory MD Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Brain E-Tattoo – Product Status 64

Brain E-Tattoo – Product Description 65

NeuroCap – Product Status 65

NeuroCap – Product Description 65

NeuroCap-19 – Paediatric – Product Status 66

NeuroCap-19 – Paediatric – Product Description 66

NeuroCap-19-Adult – Product Status 66

NeuroCap-19-Adult – Product Description 67

NeuroCap-8 Pediatric – Product Status 67

NeuroCap-8 Pediatric – Product Description 67

NeuroCap-8-Adult – Product Status 68

NeuroCap-8-Adult – Product Description 68

NeuroEEG – Product Status 68

NeuroEEG – Product Description 69

NeuroEEG Amplifier – Product Status 69

NeuroEEG Amplifier – Product Description 69

Next-Gen NeuroCap – Product Status 70

Next-Gen NeuroCap – Product Description 70

Memory MD Inc – Ongoing Clinical Trials Overview 71

NeuroEEG – Psilocybin Data Study Between Silo Wellness and Ehave Using Brain Scientific Mapping Neurocap 72

Mindful Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 73

Halifax Consciousness Scanner – Product Status 73

Halifax Consciousness Scanner – Product Description 73

Neba Health, LLC Pipeline Products & Ongoing Clinical Trials Overview 74

NEBA Device – Dementia – Product Status 74

NEBA Device – Dementia – Product Description 74

NEBA Device – Depression – Product Status 75

NEBA Device – Depression – Product Description 75

Neuro Assessment Systems Pipeline Products & Ongoing Clinical Trials Overview 76

NeuroScreen System – Product Status 76

NeuroScreen System – Product Description 76

Neurolutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

Home-Based EEG Screening System – Product Status 77

Home-Based EEG Screening System – Product Description 77

NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 78

Evo SEEG System – Long Term Use – Product Status 78

Evo SEEG System – Long Term Use – Product Description 78

NeuroServo Inc Pipeline Products & Ongoing Clinical Trials Overview 79

VEEGix – Autistic Disorder – Product Status 79

VEEGix – Autistic Disorder – Product Description 79

VEEGix – Post Operative Delirium – Product Status 80

VEEGix – Post Operative Delirium – Product Description 80

NeuroServo Inc – Ongoing Clinical Trials Overview 81

VEEGix – Post Operative Delirium – Pediatric Delirium Screening in the PICU Via EEG 82

Neuroverse Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Brainstation System – Product Status 83

Brainstation System – Product Description 83

NeuroVigil Inc Pipeline Products & Ongoing Clinical Trials Overview 84

iBrain Device – Product Status 84

iBrain Device – Product Description 84

NeuroWave Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 85

NeuroMedic Seizure Detection Device – Product Status 85

NeuroMedic Seizure Detection Device – Product Description 85

SeizTBI Device – Product Status 86

SeizTBI Device – Product Description 86

Optima Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 87

CereScope – Product Status 87

CereScope – Product Description 87

QUASAR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88

NEMO (Neonatal EEG Monitor) – Product Status 88

NEMO (Neonatal EEG Monitor) – Product Description 88

Rice University Pipeline Products & Ongoing Clinical Trials Overview 89

Wireless Monitor – Intractable Epilepsy – Product Status 89

Wireless Monitor – Intractable Epilepsy – Product Description 89

Shenzhen Med-link Electronics Tech Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Medlinket Anaesthesia Depth EEG Sensor – Product Status 90

Medlinket Anaesthesia Depth EEG Sensor – Product Description 90

Skolkovo Institute of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 91

Portable Device – Electroencephalography – Product Status 91

Portable Device – Electroencephalography – Product Description 91

Sumitomo Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

Wearable EEG Meter – Product Status 92

Wearable EEG Meter – Product Description 92

UNEEG Medical A/S Pipeline Products & Ongoing Clinical Trials Overview 93

24/7 EEG SubQ – Product Status 93

24/7 EEG SubQ – Product Description 94

24/7 EEG SubQ – Children – Product Status 94

24/7 EEG SubQ – Children – Product Description 94

EarEEG – Product Status 95

EarEEG – Product Description 95

Hyposafe Subq – Product Status 95

Hyposafe Subq – Product Description 96

UNEEG Medical A/S – Ongoing Clinical Trials Overview 97

Hyposafe Subq – Investigation of Hypoglycaemia-induced EEG Changes in Participants With Type 1 Diabetes by Use of the Hyposafe H02 Device 98

24/7 EEG SubQ – Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients with Temporal Lobe Epilepsy An Open-label, Prospective, Paired, Comparative Study 99

24/7 EEG SubQ – Sleep in the Ultra Long-term Perspective: Seasonality and Behaviorally Induced Variation 99

24/7 EEG SubQ – Study Title: Evaluation of the 24/7 EEG SubQ System in Subjects with Uncontrolled Genetic Generalised Epilepsy Syndrome 99

University College Cork Pipeline Products & Ongoing Clinical Trials Overview 100

NEOPRISM – Product Status 100

NEOPRISM – Product Description 100

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 101

Neurobiological Recording Device – Product Status 101

Neurobiological Recording Device – Product Description 101

QEEG Test – Product Status 102

QEEG Test – Product Description 102

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 103

ActiveInvasive EEG – Product Status 103

ActiveInvasive EEG – Product Description 103

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 104

Brain Electrical Activity Monitoring System – Product Status 104

Brain Electrical Activity Monitoring System – Product Description 104

University of Helsinki Pipeline Products & Ongoing Clinical Trials Overview 105

EEG-Based Biomonitor – Product Status 105

EEG-Based Biomonitor – Product Description 105

Preterm EEG Analyzer – Product Status 106

Preterm EEG Analyzer – Product Description 106

University of Hertfordshire Pipeline Products & Ongoing Clinical Trials Overview 107

Wireless EEG Sensing Device – Product Status 107

Wireless EEG Sensing Device – Product Description 107

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 108

Brain-Heart Monitoring Device – Product Status 108

Brain-Heart Monitoring Device – Product Description 108

University of Tsukuba Pipeline Products & Ongoing Clinical Trials Overview 109

In-Home Sleep EEG Device – Product Status 109

In-Home Sleep EEG Device – Product Description 109

University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 110

Electrode Device – Electroencephalography – Product Status 110

Electrode Device – Electroencephalography – Product Description 110

Wyss Center for Bio and Neuro Engineering Pipeline Products & Ongoing Clinical Trials Overview 111

Epios System – Product Status 111

Epios System – Product Description 111

Wyss Center for Bio and Neuro Engineering – Ongoing Clinical Trials Overview 112

Epios System – Early Feasibility Study on Epios Leads 113

Glossary 133

Figures

Electroencephelographs (EEG) – Pipeline Products by Stage of Development 13

Electroencephelographs (EEG) – Pipeline Products by Territory 14

Electroencephelographs (EEG) – Pipeline Products by Regulatory Path 15

Electroencephelographs (EEG) – Pipeline Products by Estimated Approval Date 16

Electroencephelographs (EEG) – Ongoing Clinical Trials 17

Frequently asked questions

Electroencephelographs (EEG) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Electroencephelographs (EEG) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Electroencephelographs (EEG) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Electroencephelographs (EEG) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.